The abstract is read at the publisher; the summary is JClub's.
Receiving at least one dose of a rotavirus vaccine is linked to 75·8% adjusted vaccine effectiveness against rotavirus-positive acute gastroenteritis mortality in children aged ≥3 months.
- Why it matters: Rotavirus causes a substantial share of diarrhoea deaths in children under 5, and evidence on vaccine protection against death is needed to guide delivery and policy.
- What they did: Pooled test-negative case-control data from 27,252 children under 5 across 22 countries (2007–2023) were analyzed with unconditional logistic regression adjusted for national under-5 mortality strata and child age.
- The result: Among children aged ≥3 months with routine vaccination in countries reporting at least one acute gastroenteritis death, vaccine effectiveness was 75·8% (95% CI 28·4 to 91·8; n=13,630) for rotavirus-positive deaths and 20·8% (-47·0 to 57·3; n=20,005) for all-cause deaths.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.